Biocause News and Activities
Presence
Biocause develops, manufactures, and sells pharmaceutical products and health care ingredients. Its main products include medicines, active ingredients, and health products for hospitals, clinics, distributors, and consumer health customers.
Biocause products and services overview:
- Prescription drugs
- Active ingredients
- Biopharmaceuticals
- Health products
- Diagnostic reagents
Revenue: ~$430 million
Employees: 3,200
Headquarters: Hefei, China
Biocause is one of the...
Biocause is a company listed under the stock ticker 000627 (CN).
Executives
View the org chart displaying its 6 main executives
Most searched biographies at Biocause
- Wenxia Zhou, Vice Chairman of the Board, Chief Executive Officer
- Xiaomiao Zhang, Independent Director
- Bing Hu, Independent Director
Create your alert
to follow the executive moves at Biocause.
Pharmaceuticals
Biocause has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Biocause
Social media about Biocause
- Biocause on Wikipedia, Google News & Yahoo Finance
- Biocause on LinkedIn, X (Twitter) & YouTube
